President, Chief Executive Officer and Director, Indigo Ag. Serial entrepreneur who has founded and built three innovative companies in the last 20 years, leading the last two through successful IPOs and to multibillion-dollar market capitalizations, and raising over $1.2 billion. Most recently Chief Executive Officer and Co-Founder, Anacor Pharmaceuticals, a biopharmaceutical company discovering and developing novel small-molecule therapeutics to treat infectious and inflammatory diseases. The company was acquired by Pfizer in 2016 for approximately $5.2 billion. Previously co-founded and served as Chief Executive Officer, Chemdex, later creating its parent company Ventro Corporation, a business-to-business marketplace focused on the life sciences industry. Founder and Chairman, San Francisco-based digital health start-up Better Therapeutics and a board director of the human microbiome company Evelo Biosciences. Named Entrepreneur of the Year in Northern California by Ernst and Young (2000). BSc in Chemical Engineering, University of Tulsa; MBA, Harvard Business School; attended the United States Air Force Academy, National Merit Scholar.